King® Guide to Parenteral Admixtures®
Loose-Leaf Edition

The Original Standard in Hospital Pharmacy Since 1971

Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.

King Guide loose-Leaf Edition

"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.

Features

  • Updated Quarterly Since 1971
  • Exceeds TJC Requirements
  • NABP Endorsed
  • Over 600 IV drugs with at-a-glance view of compatibility in 12 fluids
  • Over 3,350 Primary Source References
  • Includes routes, dosages, temperatures, and containers used to determine compatibility and stability.
  • Y-Site, Syringe, and other sets/container specific information.
  • Extensive TPN/TNA data.
  • Special Sections on Stability and Storage
  • Boxed Warning and Hazardous Drugs List and Identification
  • Proprietary and Generic Drug Names Included

Fall 2025

In this Supplement, we added a new monograph for LANDIOLOL HYDROCHLORIDE.

We added new stability information to the monographs for GEMCITABINE HYDROCHLORIDE, PEMBROLIZUMAB, and SUFENTANIL CITRATE.

Compatibility information was added for these drugs:  MORPHINE SULFATE, ROPIVACAINE HYDROCHLORIDE, TOTAL PARENTERAL NUTRITION SOLUTIONS, and ZICONOTIDE; and CAFFEINE CITRATE with 43 other drugs.


Ready to Order?

Visit our Online Store

Buy Now

Stay Informed Of Drugs With New Information
Join Our Newsletter